Establishing Clinically Relevant Severity Levels for the Central Sensitization Inventory

被引:184
|
作者
Neblett, Randy [1 ]
Hartzell, Meredith M. [1 ]
Mayer, Tom G. [2 ]
Cohen, Howard [3 ]
Gatchel, Robert J. [4 ]
机构
[1] PRIDE Res Fdn, Dallas, TX USA
[2] Univ Texas Southwestern Med Ctr Dallas, Dept Orthoped Surg, 5701 Maple Ave 100, Dallas, TX 75235 USA
[3] Univ Texas Arlington, Grad Sch Nursing, Arlington, TX 76019 USA
[4] Univ Texas Arlington, Dept Psychol, Arlington, TX 76019 USA
关键词
central sensitization inventory; central sensitization; central sensitivity syndrome; chronic pain; CENTRAL SENSITIVITY SYNDROMES; OCCUPATIONAL MUSCULOSKELETAL DISORDERS; PAIN DISABILITY QUESTIONNAIRE; IRRITABLE-BOWEL-SYNDROME; PSYCHIATRIC-DISORDERS; FIBROMYALGIA SYNDROME; RISK-FACTORS; DEPRESSION; PREVALENCE; CLASSIFICATION;
D O I
10.1111/papr.12440
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
ObjectivesThe aim of this study was to create and validate severity levels for the central sensitization inventory (CSI), a valid and reliable patient-reported outcome instrument designed to identify patients whose presenting symptoms may be related to a central sensitivity syndrome (CSS; eg, fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome), with a proposed common etiology of central sensitization (CS). MethodsBased on CSI score means and standard deviations from previously published subject samples, the following CSI severity levels were established: subclinical = 0 to 29; mild = 30 to 39; moderate = 40 to 49; severe = 50 to 59; and extreme = 60 to 100. The concurrent validity of the CSI severity levels was then confirmed in a separate chronic pain patient sample (58% with a CSS diagnosis and 42% without) by demonstrating associations between CSI scores and (1) the number of physician-diagnosed CSSs; (2) CSI score distributions in both CSS and non-CSS patient samples; (3) patient-reported history of CSSs; and (4) patient-reported psychosocial measures, which are known to be associated with CSSs. ResultsCompared to the non-CSS patient subsample, the score distribution of the CSS patient subsample was skewed toward the higher severity ranges. CSI mean scores moved into higher severity levels as the number of individual CSS diagnoses increased. Patients who scored in the extreme CSI severity level were more likely to report previous diagnoses of fibromyalgia, chronic fatigue syndrome, temporomandibular joint disorder, tension/migraine headaches, and anxiety or panic attacks (P < 0.01). CSI severity levels were also associated with patient-reported depressive symptoms, perceived disability, sleep disturbance, and pain intensity (P 0.02). ConclusionThis study provides support for these CSI severity levels as a guideline for healthcare providers and researchers in interpreting CSI scores and evaluating treatment responsiveness.
引用
收藏
页码:166 / 175
页数:10
相关论文
共 50 条
  • [21] The central sensitization inventory: A user's manual
    Neblett, Randy
    JOURNAL OF APPLIED BIOBEHAVIORAL RESEARCH, 2018, 23 (02)
  • [22] Effect of central sensitization inventory on the number of painful sites and pain severity in a Japanese regional population cohort
    Hoshino, Hironobu
    Sasaki, Nao
    Ide, Koichiro
    Yamato, Yu
    Watanabe, Yuh
    Matsuyama, Yukihiro
    JOURNAL OF ORTHOPAEDIC SCIENCE, 2022, 27 (04) : 929 - 934
  • [23] The Development and Psychometric Validation of the Central Sensitization Inventory
    Mayer, Tom G.
    Neblett, Randy
    Cohen, Howard
    Howard, Krista J.
    Choi, Yun H.
    Williams, Mark J.
    Perez, Yoheli
    Gatchel, Robert J.
    PAIN PRACTICE, 2012, 12 (04) : 276 - 285
  • [24] Validity of the central sensitization inventory with measures of sensitization in people with knee osteoarthritis
    Jonathan Gervais-Hupé
    Jasmine Pollice
    Jackie Sadi
    Lisa C. Carlesso
    Clinical Rheumatology, 2018, 37 : 3125 - 3132
  • [25] Validity of the central sensitization inventory with measures of sensitization in people with knee osteoarthritis
    Gervais-Hupe, Jonathan
    Pollice, Jasmine
    Sadi, Jackie
    Carlesso, Lisa C.
    CLINICAL RHEUMATOLOGY, 2018, 37 (11) : 3125 - 3132
  • [26] THE SEVERITY OF HEROIN DEPENDENCE: DOES IT EXIST AND IS IT CLINICALLY RELEVANT?
    Shand, Fiona L.
    Slade, Tim
    Degenhardt, Louisa
    Nelson, Elliot C.
    DRUG AND ALCOHOL REVIEW, 2009, 28 : A58 - A58
  • [27] ARE PLASMA DRUG LEVELS CLINICALLY RELEVANT - REPLY
    SOMMERS, DK
    SOUTH AFRICAN MEDICAL JOURNAL, 1982, 61 (18): : 650 - 650
  • [28] THE EFFECT OF CENTRAL SENSITIZATION ON DISEASE SEVERITY LEVELS AND PRESENTEEISMRELATED PRODUCTIVITY LOSS IN FEMALE WORKERS WITH RA
    Farah, S.
    Spinelli, F. R.
    Quartuccio, L.
    Bazzani, C.
    Nacci, F.
    Fornaro, M.
    Iacono, D.
    Baldi, C.
    Perniola, S.
    Longhino, S.
    Salaffi, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 812 - 813
  • [29] Validity and reliability of the Turkish version of the central sensitization inventory
    Keles, Ela Duzce
    Birtane, Murat
    Ekuklu, Galip
    Kilincer, Cumhur
    Caliyurt, Okan
    Tastekin, Nurettin
    Is, Enes Efe
    Ketenci, Aysegul
    Neblett, Randy
    ARCHIVES OF RHEUMATOLOGY, 2021, 36 (04) : 518 - 526
  • [30] Measurement Properties of the Central Sensitization Inventory: A Systematic Review
    Scerbo, Thomas
    Colasurdo, Joseph
    Dunn, Sally
    Unger, Jacob
    Nijs, Jo
    Cook, Chad
    PAIN PRACTICE, 2018, 18 (04) : 544 - 554